TACKLING THE MRSA EPIDEMIC

Similar documents
Rise of Resistance: From MRSA to CRE

Ca-MRSA Update- Hand Infections. Washington Hand Society September 19, 2007

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?

Infections caused by Methicillin-Resistant Staphylococcus

Methicillin Resistant Staphylococcus aureus:

MRSA. ( Staphylococcus aureus; S. aureus ) ( community-associated )

GUIDE TO INFECTION CONTROL IN THE HOSPITAL

Source: Portland State University Population Research Center (

Methicillin Resistant Staphylococcus Aureus (MRSA) The drug resistant `Superbug that won t die

Staphylococcus Aureus

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Impact of a Standardized Protocol to Address Outbreak of Methicillin-resistant

Nosocomial Infections: What Are the Unmet Needs

Burden of disease of antibiotic resistance The example of MRSA. Eva Melander Clinical Microbiology, Lund University Hospital

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

Appropriate antimicrobial therapy in HAP: What does this mean?

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana

Antimicrobial stewardship: Quick, don t just do something! Stand there!

HEALTH SERVICES POLICY & PROCEDURE MANUAL

MRSA Outbreak in Firefighters

Konsequenzen für Bevölkerung und Gesundheitssysteme. Stephan Harbarth Infection Control Program

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

Methicillin-Resistant Staphylococcus aureus

Appropriate Antimicrobial Therapy for Treatment of

Skin & Soft Tissue Infections (SSTI) Skin & Soft Tissue Infections. Skin & Soft Tissue Infections (SSTI)

Le infezioni di cute e tessuti molli

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

Antimicrobial Susceptibility Patterns

Antibiotic Updates: Part II

Summary of the latest data on antibiotic resistance in the European Union

Prevalence & Risk Factors For MRSA. For Vets

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

New Antibiotics for MRSA

Skin & Soft Tissue Infections (SSTIs)

Why should we care about multi-resistant bacteria? Clinical impact and

Infectious Disease Update 2017

Concise Antibiogram Toolkit Background

ANTIMICROBIAL STEWARDSHIP: THE ROLE OF THE CLINICIAN SAM GUREVITZ PHARM D, CGP BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCES

Evaluating the Role of MRSA Nasal Swabs

Beta-lactam antibiotics - Cephalosporins

Active Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.

Skin and Soft Tissue Infections Emerging Therapies and 5 things to know

FM - Male, 38YO. MRSA nasal swab (+) Due to positive MRSA nasal swab test, patient will be continued on Vancomycin 1500mg IV q12 for MRSA treatment...

Necrotizing Soft Tissue Infections: Emerging Bacterial Resistance

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

CA-MRSA: How Should We Respond to Outbreaks?

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

The Rise of Antibiotic Resistance: Is It Too Late?

Antimicrobial Cycling. Donald E Low University of Toronto

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Hospital Acquired Infections in the Era of Antimicrobial Resistance

Antimicrobial Resistance

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

RESISTANT PATHOGENS. John E. Mazuski, MD, PhD Professor of Surgery

Imagine. Multi-Drug Resistant Superbugs- What s the Big Deal? A World. Without Antibiotics. Where Simple Infections can be Life Threatening

M R S A. Methicillin-Resistant Staphylococcus aureus. The Facts

Staph Cases. Case #1

CHAPTER 1 INTRODUCTION

Lindsay E. Nicolle University of Manitoba Winnipeg, CANADA

Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship

MRSA Background. New Challenges From an Old Foe. MRSA Demographics. Comparison of Types of MRSA CA-MRSA HA-MRSA

Antibiotic Updates: Part I

In-Service Training Program. Managing Drug-Resistant Organisms in Long-Term Care

Multi-Drug Resistant Organisms (MDRO)

Significant human pathogen. SSTI Biomaterial related infections Osteomyelitis Endocarditis Toxin mediated diseases TSST Staphylococcal enterotoxins

Staphylococcus aureus

Best Antimicrobials for Staphylococcus aureus Bacteremia

Screening programmes for Hospital Acquired Infections

What s New in MRSA? An Update on Legislative Mandates and MRSA in the Obstetrics/ Gynecology Patient

MDRO in LTCF: Forming Networks to Control the Problem

Antimicrobial stewardship in managing septic patients

Replaces:04/14/16. Formulated: 1997 SKIN AND SOFT TISSUE INFECTION

Appropriate Antibiotic Prescribing: Making Good Choices for Bad Bugs. Disclosure 4/22/17

Infection Control Manual Residential Care Part 3 Infection Control Standards IC7: 0100 Methicillin Resistant Staphylococcus aureus

North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose

A LONGITUDINAL STUDY OF COMMUNITY-ASSOCIATED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS COLONIZATION IN COLLEGE SPORTS PARTICIPANTS

Resistant Infections: Superbugs and No Superdrugs

3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats

STAPHYLOCOCCI: KEY AST CHALLENGES

Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles

An Approach to Appropriate Antibiotic Prescribing in Outpatient and LTC Settings?

Today s Agenda: 9/30/14

Evolution of antibiotic resistance. October 10, 2005

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

Infectious Disease Issues in the Intensive Care Unit

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Activity C: ELC Prevention Collaboratives

LINEE GUIDA: VALORI E LIMITI

Epidemiology of Community- Associated (CA) Methicillin-Resistant Staphylococcus aureus (MRSA) in the United States

Is biocide resistance already a clinical problem?

Bacterial infections complicating cirrhosis

2016 Antibiotic Susceptibility Report

Community-Associated Methicillin-Resistant Staphylococcus aureus: Review of an Emerging Public Health Concern

Transcription:

TACKLING THE MRSA EPIDEMIC Paul D. Holtom, MD Associate Professor of Medicine and Orthopaedics USC Keck School of Medicine MRSA Trend (HA + CA) in US TSN Database USA (1993-2003) % of MRSA among S. aureus Isolates 45 40 35 30 25 20 15 10 25.1 26.2 CA-MRSA 29.1 36.0 42.5 48.5 1993 1995 1997 1999 2001 2003 Year MDR = multidrug resistant, CA = community-acquired. TSN Database, USA, Focus Technologies. Data on file, Ortho-McNeil Pharmaceutical, Inc. Evolution of Drug Resistance in S. aureus Penicillin Methicillin S. aureus Penicillin-resistant Methicillinresistant [1960s] [1950s] S. aureus S. aureus (MRSA)

METHICILLIN RESISTANCE IN S. AUREUS 1961: First reports in Europe 1965: First hospital outbreak in US Barber. J Clin Path 14:385; 1961 Jevons. Br. Med J. 1:124, 1961 Barrett. NEJM. 279:441, 1965 METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS Contains meca gene for PBP-2a PBP-2a has low affinity for all _ lactams: Penicillins Cephalosporins Carbapenems meca gene located on mobile element integrates into specific site of chromosome Evolution of Drug Resistance in S. aureus Penicillin Methicillin S. aureus Penicillin-resistant [1960s] [1950s] S. aureus S. aureus (MRSA) [1997] Vancomycin Vancomycinresistant S. aureus Vancomycin Methicillinresistant intermediateresistant S. aureus (VISA) [1990s] Vancomycin-resistant enterococci (VRE)

HEALTH-CARE ASSOCIATED MRSA Prevalence of MRSA Proportion of S. aureus Nosocomial Infections Resistant to Oxacillin (MRSA) Among Intensive Care Unit Patients,1989-2004 70 2004 60 63% 50 Percent Resistance 40 30 20 10 0 *Source: NNIS System. 1989 1991 1993 1995 1997 1999 2001 2003 Year Centers for Disease Control and Prevention Web site. Available at: http://www.cdc.gov/ncidod/dhqp/pdf/ar/icu_restrend1995-2004.pdf. Accessed March 6, 2006. METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS Classical hospital-acquired ORSA Contains SCCmec Types [I,] II, or III Usually shows resistance to: Tetracyclines Macrolides Quinolones Rifampin Aminoglycosides

HA-MRSA Strains show multi-drug resistance Not spread in the community setting?slower growth than OSSA?lack of antibiotic pressure in environment Risk Factors for MRSA Setting Hospitals Long-Term Care Facilities Risk Factors for Infection and Colonization ν Previous hospital stay 1,2 ν Prolonged length of stay prior to infection 1 ν Surgical procedure(s) 1 ν Enteral feeding 1 ν Levofloxacin use 1 ν Presence of decubitus ulcer 3 ν Presence of wounds 3 Prior Antibiotic Exposure 4,5 ν Third-generation cephalosporins 6 ν Fluoroquinolones 1,7,8 1.Graffunder EM, Venezia RA. J Antimicrob Chemother. 2002;49:999-1005. 5.Law MR et al. Epidemiol Infect. 1988;101:623-629. 2.Asensio A et al. Infect Control Hosp Epidemiol. 1996;17:20-28. 6. Peacock JE et al. Ann Intern Med. 1980;93:526-532. 3.Terpenning MS, et al. J Am Geriatr Soc. 1994;42:1062-1069. 7. Evans ME et al. J Antimicrob Chemother. 1998;41:285-288. 4.Hershow RC et al. Infect Control Hosp Epidemiol. 1992;13:587-593. 8.Harbarth S et al. Clin Infect Dis. 2000;31:1380-1385. Risk Factors Associated Independently with MRSA Infection Risk Factor OR 95% CIs P Value Levofloxacin use 8.01 3.15, 20.3 <0.001 Enteral feeding 2.55 1.37, 4.72 0.003 Surgery 2.24 1.19, 4.22 0.01 Previous hospitalization Length of stay before culture 1.95 1.03 1.02, 3.76 1.0, 1.07 0.04 0.05 Graffunder EM, Venezia RA. J Antimicrob Chemother. 2002;49:999-1005.

HA-MRSA INFECTIONS BY ORGAN SYSTEM Urinary tract 20% Other 12% Skin soft tissue 36% Bloodstream 9% Respiratory 22% Otitis media externa 1% Naimi TS et al. JAMA. 2003;290:2976-2984 Mortality Associated with Bacteremia Due to MRSA vs. MSSA Outcome Recovered MRSA-infected Patients 70.4% MSSA-infected Patients 86.4% Died of other causes Died of infection* 17.8% 11.8% 8.5% 5.1% *P<0.001 Melzer M, et al. Clin Infect Dis. 2003;37:1453-1460. S. aureus Surgical Site Infections : Impact of Methicillin Resistance on Outcomes All-cause 90-day mortality, unadjusted (%) 30 20 10 0 25/121 Independent effect of MRSA: OR 3.4 (95% CI 1.5-7.2, P = 0.003) After adjusting for age, ASA score, duration of surgery 11/165 4/193 MRSA MSSA Controls ASA Score: American Society of Anesthesiologists score of pre-operative physical fitness Engemann JJ, Carmeli Y, Cosgrove SE, et al. 2003 Clin Infect Dis. 36:592-598.

COMMUNITY ASSOCIATED MRSA COMMUNITY ASSOCIATED MRSA (CA-MRSA) Different from HA-MRSA Epidemiologically Clinically Genetically CDC Definition of CA-MRSA Diagnosis of MRSA made in the outpatient setting OR culture positive for MRSA 48 hr of hosp admission No medical history of MRSA colonization or infection www.cdc.gov

CDC Definition of CA-MRSA No medical history in the past year of: Hospitalization Admission to nursing home, SNF or hospice Dialysis Surgery No indwelling catheters or medical devices that pass through the skin www.cdc.gov MRSA AS COMMUNITY PATHOGEN Associated with SSTI CA-MRSA Urinary tract 1% Bloodstream 4% Respiratory 6% Otitis media externa 7% Other 8% Skin soft tissue 74%

MRSA AS COMMUNITY PATHOGEN Associated with SSTI Genetically different than HA-MRSA SCCmec Type IV CA-MRSA TOXINS Panton-Valentine leukocidin Superantigen enterotoxin H 15 additional unique superantigen genes 11 exotoxin genes 4 enterotoxin genes Strain MW2 demonstrated 10 times stronger human-t cell proliferation than other S. aureus strains May correlate with high virulence Baba T, et al. Lancet. 2002;359(9320):1819-1827

RISK FACTORS FOR CA-MRSA IVDU MSM Correctional institutions Homelessness/marginally housed CA-MRSA in CORRECTIONAL FACILITIES Los Angeles County Jail (N=165,000) 2002: 928 inmates with MRSA infections 66 hospitalized, most with SSTI 10 with invasive disease (bacteremia, endocarditis, osteomyelitis) 2003: 1849 cases 2004: 2480 cases MMWR. 2003;52(5):88 Ngo V, et al. Abstract 32, SHEA, 2005

CA-MRSA in CORRECTIONAL FACILITIES Folliculitis, furuncles, boils, abscesses Spider bites Risks: previous antibiotics, skin trauma, sharing soap, hand-washing clothes, self-draining boils, recent arrival to facility MMWR. 2003;52(5):88 Tobin et al. IDSA 2003 CA-MRSA in COMPETITIVE ATHLETES Wrestlers (Indiana) 2 wrestlers from different weight groups Fencing club (Colorado) Skin abscesses, paraspinal myositis, bacteremia Risks: sharing sensor wires? shared clothing MMWR. 2003;52(5):88 CA-MRSA in COMPETITIVE ATHLETES Collegiate football players in Pennsylvania, Wisconsin, California Professional football players Miami Dolphins St. Louis Rams 5 of 58 players (9%); 8 infections Lineman or linebackers MMWR. 2003;52(5):88 NEJM 2005; 352:468-475

RISK FACTORS FOR CA-MRSA IVDU MSM Correctional institutions Homelessness/marginally housed Athletes Post-influenza pneumonia Clinical Implications of CA-MRSA Outpatient & Emergency Dept settings Consider medical practice modification in areas with high prevalence of CA-MRSA: More frequent C & S testing of potential S. aureus skin infections, especially in pediatrics Surgical drainage of infection, when appropriate Careful selection of empiric antibiotics for suspected staphylococcal infections when treatment is indicated Careful patient and laboratory follow-up Naimi et al. JAMA 2003;290:2976-84 THERAPEUTIC OPTIONS Community-acquired MRSA Frequently sensitive to multiple drugs Old, inexpensive drugs such as TMP/SMX, tetracycline, clindamycin can often be used

THERAPEUTIC OPTIONS Community-acquired MRSA Frequently sensitive to multiple drugs Old, inexpensive drugs such as TMP/SMX, tetracycline, clindamycin can often be used Hospital-acquired MRSA Usually multi-drug resistant THERAPEUTIC OPTIONS Glycopeptides (Vancomycin) Streptogramins (Synercid) Oxazolidinones (Linezolid) Daptomycin Tigecycline (Glycylcycline) COMING NEW DRUGS Telavancin Ceftibiprole

PREVENTION OF MRSA Impact of Hand Hygiene on Hospital Infections Year Author Setting Impact on Infection Rate 1977 Casewell adult ICU Klebsiella decreased 1982 Maki adult ICU decreased 1984 Massanari adult ICU decreased 1990 Simmons adult ICU no effect 1992 Doebbeling adult ICU decreased with one versus another hand hygiene product 1994 Webster NICU MRSA eliminated 1995 Zafar nursery MRSA eliminated 1999 Pittet hospital MRSA decreased Source: Pittet D: Emerg Infect Dis 2001;7:234-240 Link to: Improving hand hygiene FINAL THOUGHTS ON MRSA CA-MRSA is spreading rapidly and may become the dominant strain soon both in hospitals and community No new oral drugs will be released in the near future High index of suspicion and good hand hygiene are key to treatment and prevention

Human destiny is bound to remain a gamble, because at some unpredictable time and in some unforeseeable manner, nature will strike back. Mirage of Health, Rene Dubos, 1959 THANK YOU